Fluid-therapy, Thoracic Surgery
Conditions
Keywords
pulse pressure variation, zero balance, single-lung ventilation
Brief summary
Peri-operative fluid-therapy is extremely important in thoracic surgery, because excessive administration of fluids during one-lung ventilation is correlated to an increasing risk of postoperative respiratory complications. Therefore, current guidelines on peri-operative management of patients undergoing thoracic surgery suggest a conservative fluid management strategy, based on intra-operative fluid loss replacement and maintenance of euvolemia. Nevertheless, intra-operative fluid loss estimation and consequently the correct infusion rate adoption are quite difficult to be addressed in clinical practice, and this often prevents the euvolemia maintenance in the peri-operative period. This limit claims the necessity to adopt new methods of fluid-therapy administration in thoracic surgery; among these the most promising is the Goal-Directed Therapy (GDT). GDT protocols based on Stroke Volume Variation (SVV) or Pulse Pressure Variation (PPV) monitoring have been adopted successfully in major and cardiac surgery but not yet in thoracic surgery. The aim of this randomized study is to evaluate the effects of a PPV-GDT fluid management protocol versus a conservative zero-balance protocol on intrapulmonary gas exchanges, in patients undergoing single-lung ventilation during thoracic surgery.
Detailed description
The intra-operative fluid-therapy (using lactated Ringer) will be based on pulse pressure variation (PPV group) with a target ≤5.8% or on compensation (1:1) of urine output (zero balance group). In both groups an intraoperative background infusion of lactated Ringer at 1-2 ml/kg/h will be administered.
Interventions
fluid-therapy based on PPV monitoring
fluid-therapy based on urinary output balance
Sponsors
Study design
Intervention model description
Randomized clinical trial
Eligibility
Inclusion criteria
* Adult patients scheduled for Video-assisted thoracic surgery (VATS) lobectomy
Exclusion criteria
* Patients who will not sign the informed consent * Obesity (BMI \> 35 kg/m2) * Cardiovascular disease (heart failure, arrhythmia) * OSAS requiring or not C-PAP therapy * Chronic alcoholism * intraoperative blod loss\> 1500 ml * One-lung ventilation duration\< 60 min
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| PaO2/FiO2 ratio | 15 minutes after extubation | Ratio of arterial oxygen partial pressure (PaO2 in mmHg) to fraction of inspired oxygen (FiO2) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative pulmonary complications | Up to 3 days after surgery | e.g. Atelectasis, pneumonia, lung edema, pleural effusion, hypoxemia |
| In-hospital stay | Days until discharge, an average of 5 days | Hospital stay duration |
Countries
Italy